{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:49:32Z","timestamp":1791139772372,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1093\/ndt\/gfu087","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T22:49:33Z","timestamp":1397602173000},"page":"1910-1918","source":"Crossref","is-referenced-by-count":43,"title":["Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure"],"prefix":"10.1093","volume":"29","author":[{"given":"Catriona","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslyn J.","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pitcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,4,15]]},"reference":[{"key":"key\n\t\t\t\t20170515170646_GFU087C1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"issue":"suppl1","key":"key\n\t\t\t\t20170515170646_GFU087C2","first-page":"1","article-title":"UK Renal Registry 15th annual report: Chapter 1 UK RRT incidence in 2011: national and centre-specific analyses","volume":"123","author":"Gilg","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170515170646_GFU087C3"},{"key":"key\n\t\t\t\t20170515170646_GFU087C4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ndt\/gfr764","article-title":"The ERA-EDTA Working Group on inherited kidney disorders","volume":"27","author":"Devuyst","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515170646_GFU087C5","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"CRISP Investigators: Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515170646_GFU087C6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515170646_GFU087C7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2215\/CJN.09500911","article-title":"Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease","volume":"7","author":"Chapman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515170646_GFU087C8","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515170646_GFU087C9","doi-asserted-by":"crossref","first-page":"e53016","DOI":"10.1371\/journal.pone.0053016","article-title":"Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study","volume":"8","author":"Kistler","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170515170646_GFU087C10","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1093\/ndt\/gfr744","article-title":"The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease","volume":"27","author":"Reed","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515170646_GFU087C11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/01.ASN.0000013300.11876.37","article-title":"The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease","volume":"13","author":"Rossetti","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515170646_GFU087C12","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hct082","article-title":"The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre","author":"Thong","year":"2013","journal-title":"QJM"},{"key":"key\n\t\t\t\t20170515170646_GFU087C13","doi-asserted-by":"crossref","first-page":"c42","DOI":"10.1159\/000334429","article-title":"Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study","volume":"120","author":"Haynes","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170515170646_GFU087C14","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2215\/CJN.01460210","article-title":"Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark","volume":"5","author":"Orskov","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515170646_GFU087C15"},{"key":"key\n\t\t\t\t20170515170646_GFU087C16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","article-title":"Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution to extrarenal complications to mortality","volume":"38","author":"Perrone","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515170646_GFU087C17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170515170646_GFU087C18","author":"Renal Association Clinical Practice Guidelines"},{"key":"key\n\t\t\t\t20170515170646_GFU087C19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD-1-PKD2 Study Group","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515170646_GFU087C20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ajkd.2007.10.037","article-title":"Variation in age at ESRD in autosomal dominant polycystic kidney disease","volume":"51","author":"Reed","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515170646_GFU087C21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2369-13-79","article-title":"Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic","volume":"13","author":"Robinson","year":"2012","journal-title":"BMC Nephrol"},{"key":"key\n\t\t\t\t20170515170646_GFU087C22","author":"Office for National Statistics"},{"key":"key\n\t\t\t\t20170515170646_GFU087C23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pcd.2010.08.002","article-title":"Type 2 diabetes and cardiovascular disease in South Asians","volume":"5","author":"Gholap","year":"2011","journal-title":"Prim Care Diabetes"},{"key":"key\n\t\t\t\t20170515170646_GFU087C24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ndt\/gfm717","article-title":"Haemoglobin and erythropoietin levels in polycystic kidney disease","volume":"23","author":"De Almeida","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515170646_GFU087C25","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1172\/JCI114280","article-title":"Erythropoietin in polycystic kidneys","volume":"84","author":"Eckardt","year":"1989","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170515170646_GFU087C26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ki.2008.352","article-title":"Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis","volume":"74","author":"Kumar","year":"2008","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515170646_GFU087C27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2011.01.019","article-title":"Peritoneal dialysis as the first-line renal replacement therapy in kidney disease","volume":"57","author":"Li","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515170646_GFU087C28","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/ndt\/gfq712","article-title":"Peritoneal dialysis in polycystic kidney disease patients. Report from the kidney peritoneal dialysis registry (RDPLF)","volume":"26","author":"Lobbedez","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515170646_GFU087C29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5414\/CNP57208","article-title":"Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival","volume":"57","author":"Abbott","year":"2002","journal-title":"Clin Nephrol"},{"issue":"suppl1","key":"key\n\t\t\t\t20170515170646_GFU087C30","doi-asserted-by":"crossref","first-page":"c187","DOI":"10.1159\/000301233","article-title":"Chapter 10: biochemistry profile of patients receiving dialysis in the UK in 2008: national and centre-specific analyses","volume":"115","author":"Dawney","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"key\n\t\t\t\t20170515170646_GFU087C31","first-page":"3561","article-title":"Patterns and effects of missing comorbidity data for patients starting renal replacement therapy in England, Wales and Northern Ireland","volume":"11","author":"Collier","year":"2011","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/29\/10\/1910\/17108754\/gfu087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T04:44:40Z","timestamp":1503549880000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfu087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,15]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,4,15]]},"published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfu087","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,15]]}}}